AU9395098A - Compositions and methods for identifying pkb kinase inhibitors - Google Patents

Compositions and methods for identifying pkb kinase inhibitors Download PDF

Info

Publication number
AU9395098A
AU9395098A AU93950/98A AU9395098A AU9395098A AU 9395098 A AU9395098 A AU 9395098A AU 93950/98 A AU93950/98 A AU 93950/98A AU 9395098 A AU9395098 A AU 9395098A AU 9395098 A AU9395098 A AU 9395098A
Authority
AU
Australia
Prior art keywords
pkb
kinase
pkb kinase
nucleotide sequence
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU93950/98A
Other languages
English (en)
Inventor
Philip Hawkings
Len Stephens
David Stokoe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Babraham Institute
Onyx Pharmaceuticals Inc
Original Assignee
Onyx Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onyx Pharmaceuticals Inc filed Critical Onyx Pharmaceuticals Inc
Publication of AU9395098A publication Critical patent/AU9395098A/en
Assigned to ONYX PHARMACEUTICALS, INC., BABRAHAM INSTITUTE, THE reassignment ONYX PHARMACEUTICALS, INC. Amend patent request/document other than specification (104) Assignors: ONYX PHARMACEUTICALS, INC.
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU93950/98A 1997-09-26 1998-09-17 Compositions and methods for identifying pkb kinase inhibitors Abandoned AU9395098A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6019097P 1997-09-26 1997-09-26
US60060190 1997-09-26
PCT/US1998/019412 WO1999016887A2 (en) 1997-09-26 1998-09-17 Compositions and methods for identifying pkb kinase inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2003200026A Division AU2003200026A1 (en) 1997-09-26 2003-01-02 Compositions and methods for identifying PKB kinase inhibitors

Publications (1)

Publication Number Publication Date
AU9395098A true AU9395098A (en) 1999-04-23

Family

ID=22027932

Family Applications (1)

Application Number Title Priority Date Filing Date
AU93950/98A Abandoned AU9395098A (en) 1997-09-26 1998-09-17 Compositions and methods for identifying pkb kinase inhibitors

Country Status (6)

Country Link
EP (1) EP1017826A2 (zh)
JP (1) JP2001518302A (zh)
CN (1) CN1276832A (zh)
AU (1) AU9395098A (zh)
CA (1) CA2298854A1 (zh)
WO (1) WO1999016887A2 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6734001B1 (en) 1997-03-17 2004-05-11 Medical Research Council 3-phosphoinositide-dependent protein kinase
WO1998041638A1 (en) 1997-03-17 1998-09-24 Medical Research Council Phosphatidyl-3,4.5-triphosphate-dependent protein kinase
AU784506B2 (en) 1999-08-25 2006-04-13 Immunex Corporation Compositions and methods for improved cell culture

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997022360A2 (en) * 1995-12-20 1997-06-26 Medical Research Council Control of protein synthesis, and screening method for agents
WO1998041638A1 (en) * 1997-03-17 1998-09-24 Medical Research Council Phosphatidyl-3,4.5-triphosphate-dependent protein kinase

Also Published As

Publication number Publication date
WO1999016887A2 (en) 1999-04-08
CN1276832A (zh) 2000-12-13
CA2298854A1 (en) 1999-04-08
EP1017826A2 (en) 2000-07-12
WO1999016887A3 (en) 1999-06-17
JP2001518302A (ja) 2001-10-16

Similar Documents

Publication Publication Date Title
Hua Chen et al. Sequence of the human glycogen-associated regulatory subunit of type 1 protein phosphatase and analysis of its coding region and mRNA level in muscle from patients with NIDDM
US6465185B1 (en) Polymorphic human PC-1 sequences associated with insulin resistance
US6218136B1 (en) Methods of the identification of pharmaceutically active compounds
JP4377050B2 (ja) サイトカイン、ストレス、およびオンコプロテインに活性化されるヒト蛋白質キナーゼキナーゼ
JP2002504804A (ja) 環状ヌクレオチドホスホジエステラーゼ
Dosé et al. Cloning and chromosomal localization of a human class III myosin
AU2001263952B2 (en) Tumour suppressor and uses thereof
US5536636A (en) Methods for identifying a tyrosine phosphatase abnormality associated with neoplastic disease
AU2001263952A1 (en) Tumour suppressor and uses thereof
JP2002539781A (ja) Ａｋｔ核酸、ポリペプチドおよびその使用
US7368113B2 (en) Hormonally up-regulated, neu-tumor-associated kinase
US5830699A (en) SOK-1 and methods of use
WO1997010252A1 (en) Dna encoding an sh2-inositol phosphatase, an shc-binding protein
AU9395098A (en) Compositions and methods for identifying pkb kinase inhibitors
US6682920B1 (en) Compositions and methods for identifying PKB kinase inhibitors
JP2002539780A (ja) 酵 素
US6511825B1 (en) Cell signaling polypeptides and nucleic acids
US6458561B1 (en) Human NIM1 kinase
US6770467B2 (en) Screening method for ligands with class II P13 kinase modulating activity
US6593099B2 (en) Regulation of human S-acyl fatty acid synthase thioesterase-like enzyme
US20070259419A1 (en) Pregnancy, up-regulated non-ubiquitous CaM kinase
US20140234321A1 (en) Hunk, a snf1-related kinase essential for mammary tumor metastasis
AU697340B2 (en) Method and product for regulating cell responsiveness to external signals
JP2001512007A (ja) Ｚｇｇｂｐ１、１型双極性感情障害に関与する新規ペプチド、配列及びその使用
US20060127913A1 (en) Alternatively spliced isoforms of human PHKA2

Legal Events

Date Code Title Description
TC Change of applicant's name (sec. 104)

Owner name: ONYX PHARMACEUTICALS, INC., THE BABRAHAM INSTITUTE

Free format text: FORMER NAME: ONYX PHARMACEUTICALS, INC.

MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted